Kezar Life Sciences(KZR) - 2025 Q2 - Quarterly Results
Exhibit 99.1 Kezar Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update SOUTH SAN FRANCISCO, Calif.—August 13, 2025 — Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical- stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune- mediated diseases, today reported financial results for the second quarter ended June 30, 2025, and provided a business update. "We are on track with our clinical development and regulatory submission ...